In this study, we leverage intracellular ATG9A mislocalization as a cellular readout for AP-4 deficiency to develop a large-scale, automated, multiparametric, unbiased phenotypic small molecule screen for modulators of ATG9A trafficking in patient-derived cellular models. The gene discussed is ATG9A; the disease is hyperinsulinemic hypoglycemia, familial, 4.